Doreen L. Weller

Resistance of Morpholino Phosphorodiamidate Oligomers to Enzymatic Degradation

Robert M. Hudziak, Elisabeth Barofsky, Douglas F. Barofsky et al. · Antisense and Nucleic Acid Drug Development · 1996 · 266 citations

<i>In vivo</i> Bioavailability and Pharmacokinetics of a <i>c-MYC</i> Antisense Phosphorodiamidate Morpholino Oligomer, AVI-4126, in Solid Tumors

Gayathri R. Devi, Tomasz M. Beer, Christopher L. Corless et al. · Clinical Cancer Research · 2005 · 109 citations · Full text

Total synthesis of of4949-III, a natural inhibitor of aminopeptidase B from ehrlich ascites carcinoma cells

Ulrich Schmidt, Doreen L. Weller, Alvin A. Holder et al. · Tetrahedron Letters · 1988 · 58 citations

Medicinal Chemistry, Biochemistry, Natural Sciences +9

Repeat-Dose Toxicology Evaluation in Cynomolgus Monkeys of AVI-4658, a Phosphorodiamidate Morpholino Oligomer (PMO) Drug for the Treatment of Duchenne Muscular Dystrophy

Peter Sazani, Kirk P. Van Ness, Doreen L. Weller et al. · International Journal of Toxicology · 2011 · 49 citations

Translational Medicine, Urology, Pharmacological Study +14

Safety Pharmacology and Genotoxicity Evaluation of AVI-4658

Peter Sazani, Doreen L. Weller, Stephen B. Shrewsbury · International Journal of Toxicology · 2010 · 41 citations

Drug Safety, Safety Pharmacology, Exon Skipping +10